2,4-dinitrobenzenesulfonic acid has been researched along with losartan potassium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuzzocrea, S; De Sarro, A; Di Paola, R; Genovese, T; Mazzon, E; MuiĆ , C; Patel, NS; Thiemermann, C | 1 |
Acet, A; Kaya, E; Parlakpinar, H; Tasdemir, S; Vardi, N | 1 |
2 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and losartan potassium
Article | Year |
---|---|
Erythropoietin reduces the development of experimental inflammatory bowel disease.
Topics: Animals; Benzenesulfonates; Colitis; Erythropoietin; Immunohistochemistry; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Male; Mice; Neutrophil Infiltration; Peroxidase; Poly Adenosine Diphosphate Ribose; Recombinant Proteins; Tumor Necrosis Factor-alpha; Tyrosine | 2004 |
Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Benzenesulfonates; Caspase 3; CD4-Positive T-Lymphocytes; Colitis; Disease Models, Animal; Drug Therapy, Combination; Epithelial Cells; Erythropoietin; Flow Cytometry; Goblet Cells; Male; Melatonin; Rats; Rats, Wistar | 2013 |